Inhibition of T cells provides protection against early invasive pneumococcal disease - Wikidata - awgldk - TriplyDB

Inhibition of T cells provides protection against early invasive pneumococcal disease

Inhibition of T cells provides protection against early invasive pneumococcal disease

http://www.wikidata.org/entity/Q34309777

about

Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets Is boosting the immune system in sepsis appropriate?Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation Toll-like receptor 4 stimulation before or after Streptococcus pneumoniae induced sepsis improves survival and is dependent on T-cells.Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection Current concepts in host-microbe interaction leading to pneumococcal pneumonia Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias Genetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infection The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.A decoy receptor 3 analogue reduces localised defects in phagocyte function in pneumococcal pneumonia.Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model A new synthesis for antibody-mediated immunity.Immune-responsiveness of CD4+ T cells during Streptococcus suis serotype 2 infection Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.L-plastin is essential for alveolar macrophage production and control of pulmonary pneumococcal infection Pneumococcal pneumonia: mechanisms of infection and resolution.The Early Adaptive Immune Response in the Pathophysiological Process of Pneumococcal Meningitis.Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree.CD80/CD86 signaling contributes to the proinflammatory response of Staphylococcus aureus in the airway.Immune response to Streptococcus pneumoniae in asthma patients: comparison between stable situation and exacerbation.

P2860

Q26830569-844DBBD3-E039-4C98-8635-10DD7BD3ACC6 Q27691996-36DFB1C8-D067-4193-8A72-EE782B3356F1 Q28744146-1F8332EF-E18D-42D8-8B83-74F5F392DA71 Q30415195-10E663D7-8BC8-4DBA-BE1E-01135B9D9EC0 Q34350904-39B79BBF-9A8E-44BE-AC59-B7AAB1321DF2 Q34540722-6DC53AAC-4FA9-474B-B0A6-1D1772EA410A Q34649770-90C78391-EE7B-468A-8316-0BEB19B4B0FD Q34754860-5AE7EF23-314B-44C1-B351-C5665B773475 Q35110974-2F27B673-C789-4806-A34C-5A4C6AD86BC7 Q35317446-EA6A71C1-3471-43F1-875F-28612EE87D37 Q36421937-673EC198-AF7F-4711-8AD5-3FE0FB41722B Q36632936-FD2AD078-6287-4EE9-A987-7FF4C5E8982E Q36660720-9D59D572-F49F-44CA-B203-5740C6520A80 Q37460131-D8FB393C-91A8-4C97-BC2A-29A45B2E7B7F Q37656365-738DC5F6-546E-4E94-AC2F-76D57DD55B4A Q37713360-50A2A1E0-12C2-45DC-AF64-7F06BF2F4614 Q38032699-6712148F-0F55-4650-8610-92F66659A653 Q40470677-CC2FCBAC-5720-41E5-A8C1-EB14012824A9 Q50133355-4EEB51D2-53D3-452D-9A1D-C3E034E9694C Q50198642-C19804BB-C144-4711-8B1F-3763B9611AE5 Q51052948-63010D15-89E5-46C0-A934-EAA5A0F32A05

P2860

Inhibition of T cells provides protection against early invasive pneumococcal disease

http://www.wikidata.org/entity/Q34309777

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Inhibition of T cells provides protection against early invasive pneumococcal disease

@ast

Inhibition of T cells provides protection against early invasive pneumococcal disease

@en

Inhibition of T cells provides protection against early invasive pneumococcal disease

@nl

type

label

Inhibition of T cells provides protection against early invasive pneumococcal disease

@ast

Inhibition of T cells provides protection against early invasive pneumococcal disease

@en

Inhibition of T cells provides protection against early invasive pneumococcal disease

@nl

prefLabel

Inhibition of T cells provides protection against early invasive pneumococcal disease

@ast

Inhibition of T cells provides protection against early invasive pneumococcal disease

@en

Inhibition of T cells provides protection against early invasive pneumococcal disease

@nl

P1433

Q34309777-F2652FB5-953F-45D1-A3ED-65FD8D8AE41A

P1476

Q34309777-7A735689-8830-426E-A9BA-C953AD4D87AB

P2093

Q34309777-D66C2D4C-DEA1-4166-BFCF-D347CFF063D5

Q34309777-EC8A198B-5187-460F-8C7D-493EBE6DE077

P2860

Q34309777-00D9E319-79EF-4B90-A939-29F2F8EFE8BE

Q34309777-03370D48-1537-4836-8CB6-AEF1CE886F03

Q34309777-03A7AB48-9270-4250-A1C3-B09363FF882D

Q34309777-04BD89C5-6756-47D2-B1FD-8855FACAF51A

Q34309777-07137304-A9AA-4BDD-8F41-65B5A08C536A

Q34309777-0A52D2A2-FB83-4588-92FE-A43950024419

Q34309777-1A4C83FB-F959-4EDA-B948-DEE3A4C9CC63

Q34309777-1B4BEE73-BDC6-4F6D-9652-BF069023CEBF

Q34309777-1C9DB248-03F0-40EE-942F-28E873FC30E1

Q34309777-2AB49687-62E8-4365-9201-8C75274CC327

P304

Q34309777-A1B077AC-6ED3-4736-A61B-43E7ABDCFF42

P31

Q34309777-9083CC33-FC68-4630-93D7-96BAA738F5D0

P356

Q34309777-6C4E8E1F-6BC1-417A-B4F7-8305412AFC1A

P407

Q34309777-8E45A5E7-887D-4E92-AE05-306A2AC692FD

P433

Q34309777-694B5A03-6034-4965-8E57-623D4DB71277

P478

Q34309777-2654B420-8A98-4807-86BD-9C4A047CF008

P50

Q34309777-1550A2AA-C465-4D78-B21B-A718080EE9CB

Q34309777-FC2457D2-BF73-43CD-84A4-7A3C162C9370

P577

Q34309777-75A2A94A-8AC6-49A7-A3BD-09715E7C2BEB

P5875

Q34309777-3BFF3CB8-4D5C-4DB0-8FA0-7C440659400B

P698

Q34309777-A3CF6123-E3FC-47BA-B35C-A2D210184D8B

P932

Q34309777-DCA80380-38B3-482F-AE17-46F0FDA43515

P356

P1433

Infection and Immunity

P1476

Inhibition of T cells provides protection against early invasive pneumococcal disease

@en

P2093

Hans Häcker

http://www.w3.org/2001/XMLSchema#string

Vanessa Redecke

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression

Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.

Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice

Streptococcus pneumoniae.

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Host cellular immune response to pneumococcal lung infection in mice.

Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model

P304

5287-5294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00431-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Elaine I Tuomanen

Kim LeMessurier

P577

2010-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46381027

http://www.w3.org/2001/XMLSchema#string

P698

20855509

http://www.w3.org/2001/XMLSchema#string

P932

2981332

http://www.w3.org/2001/XMLSchema#string